BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 7160717)

  • 1. [Intravenous verapamil for paroxysmal supraventricular tachycardia in Wolff-Parkinson-White syndrome].
    Nissimov R
    Harefuah; 1982 Mar; 102(6):234-7. PubMed ID: 7160717
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical results with verapamil in intravenous administration in the emergency therapy of cardiac arrhythmias].
    Amoroso A
    Minerva Med; 1975 May; 66(39):1904-13. PubMed ID: 1128830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verapamil induced premature ventricular beats before reversion of supraventricular tachycardia.
    Vohra J; Peter T; Hunt D; Sloman G
    Br Heart J; 1974 Dec; 36(12):1186-93. PubMed ID: 4441450
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ajmaline treatment of supraventricular paroxysmal tachycardia in Wolff-Parkinson-White syndrome. Report of a neonatal case].
    Marcer V; Dander B; Spinosa G; Buonanno C
    Minerva Pediatr; 1976 Mar; 28(11):695-700. PubMed ID: 995079
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experience with propafenone in paroxysmal supraventricular reciprocating tachycardias].
    Furlanello F; Vergara G; Dal Forno P; Disertori M; Inama G
    G Ital Cardiol; 1984 May; 14(5):379-80. PubMed ID: 6468821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous verapamil in the treatment of paroxysmal supraventricular tachycardia in children.
    Leitner RP; Hawker RE; Celermajer JM
    Aust Paediatr J; 1983 Mar; 19(1):40-4. PubMed ID: 6870700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verapamil in the treatment of paroxysmal supraventricular tachycardia.
    Krikler DM; Spurrell RA
    Postgrad Med J; 1974 Jul; 50(585):447-53. PubMed ID: 4469035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention by Propranolol of paroxysmal tachycardia of supraventricular origin. Long-term results].
    Bory M; Poggi L; d' Journo J; Serradimigni A; Audier M
    Arch Mal Coeur Vaiss; 1970 Feb; 63(2):174-81. PubMed ID: 4985972
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of calcium gluconate prior to verapamil in infants with paroxysmal supraventricular tachycardia.
    Roguin N; Shapir Y; Blazer S; Zeltzer M; Berant M
    Clin Cardiol; 1984 Nov; 7(11):613-6. PubMed ID: 6499292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of verapamil on supraventricular tachycardia in patients with overt and concealed Wolff-Parkinson-White syndrome.
    Hamer A; Peter T; Platt M; Mandel WJ
    Am Heart J; 1981 May; 101(5):600-12. PubMed ID: 7223599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antiarrhythmic efficacy of mexiletine in supraventricular arrhythmias, Wolff-Parkinson-White syndrome and persistent iterative ventricular hyperkinetic arrhythmias. Considerations on these less noted therapeutic effects].
    Menozzi C; Lolli G; Monducci I; Gheller G; Brignole M; Cattabiani ML; Vergoni W; Barone A
    Clin Ter; 1984 Feb; 108(3):199-208. PubMed ID: 6232057
    [No Abstract]   [Full Text] [Related]  

  • 12. A quick guide to converting rapid rhythms. When seconds count, use this chart to guide treatment choices.
    Sandrock J
    Nursing; 1997 Mar; 27(3):32ss. PubMed ID: 9171625
    [No Abstract]   [Full Text] [Related]  

  • 13. [Parenteral use of verapamil in supraventricular paroxysmal tachycardias].
    Barros FA; Mendonça Filho JV; Pinto RA
    Arq Bras Cardiol; 1979 May; 32(5):343-5. PubMed ID: 518381
    [No Abstract]   [Full Text] [Related]  

  • 14. [Circulatory arrest after combined intravenous drugs for the treatment of orthodromic circular tachycardia of Wolff-Parkinson-White syndrome].
    Gómez-Barrado JJ; García-Rubira JC; Turégano Albarrán S; Pavón García M; Hidalgo Urbano R; Montes Ramírez JM; Cruz Fernández JM
    Rev Esp Cardiol; 1997 Sep; 50(9):662-6. PubMed ID: 9380937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of propranolol on the Wolff-Parkinson-White syndrome].
    Demiroglu C; Göksel MF; Yavuz A; Oztürk M; Garan R
    Tip Fak Mecm; 1967; 30(2):333-6. PubMed ID: 5615227
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison between antazoline and verapamil in the treatment of paroxysmal supraventricular tachycardia].
    Haunso S; Eliasen P; Berning J; Rasmussen V; Pedersen JF; Skagen K
    Ugeskr Laeger; 1977 Nov; 139(48):2877-9. PubMed ID: 339458
    [No Abstract]   [Full Text] [Related]  

  • 17. Adenosine for the treatment of paroxysmal supraventricular tachycardia under general anesthesia in a patient with Wolff-Parkinson-White syndrome.
    Bronheim D; Neustein S
    J Cardiothorac Vasc Anesth; 1992 Apr; 6(2):218-21. PubMed ID: 1568012
    [No Abstract]   [Full Text] [Related]  

  • 18. Paroxysmal supraventricular tachycardia.
    Rogers JC
    J Am Osteopath Assoc; 1979 Jun; 78(10):733-8. PubMed ID: 468594
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of propranolol, prindolol, practolol and verapamil versus placebo on exercise induced tachycardia in patients with ventricular preexcitation.
    Vrhovac B; Bakran I; Duraković Z; Gjurasin M; Francetić I; Mohacek I
    Int J Clin Pharmacol Biopharm; 1976 Sep; 14(2):132-43. PubMed ID: 1002350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Wolff-Parkinson-White syndrome and paroxysmal tachycardia in infants. (Apropos of a case)].
    Guerricchio G
    Minerva Cardioangiol; 1972 Jan; 20(1):27-32. PubMed ID: 5060005
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.